Role of Notch signaling pathway in gastric cancer: A meta-analysis of the literature

World Journal of Gastroenterology

Volumn , Issue 27, 2014, Pages 9191-9199

  Du, Xiao ^a   Cheng, Zhong ^a   Wang, Yi Han ^a   Guo, Zi Heng ^a   Zhang, Si Qin ^a   Hu, Jian Kun ^a   Zhou, Zong Guang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Gastric cancer; Incidence; Meta analysis; Notch; Prognosis

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; DELTA LIKE 4; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CALCIUM BINDING PROTEIN; DLL4 PROTEIN, HUMAN; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; NOTCH1 PROTEIN, HUMAN; NOTCH2 PROTEIN, HUMAN; NOTCH3 PROTEIN, HUMAN; SERRATE PROTEINS; SIGNAL PEPTIDE;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; DISEASE ASSOCIATION; HUMAN; LYMPH VESSEL METASTASIS; META ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; CHI SQUARE DISTRIBUTION; METABOLISM; PATHOLOGY; RISK; STOMACH TUMOR;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIUM-BINDING PROTEINS; CHI-SQUARE DISTRIBUTION; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEOPLASM STAGING; ODDS RATIO; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84905364929     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i27.9191     Document Type: Article

References (37)

1. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol 2013; 107: 230-236 [PMID: 23129495 DOI: 10.1002/jso.23262]
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/caac.21166]
3. Correa P, Piazuelo MB, Camargo MC. Etiopathogenesis of gastric cancer. Scand J Surg 2006; 95: 218-224 [PMID: 17249268]
4. González CA, Sala N, Capellá G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002; 100: 249-260 [PMID: 12115538 DOI: 10.1002/ijc.10466]
5. Tien AC, Rajan A, Bellen HJ. A Notch updated. J Cell Biol 2009; 184: 621-629 [PMID: 19255248 DOI: 10.1083/jcb.200811141]
6. Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011; 11: 338-351 [PMID: 21508972 DOI: 10.1038/nrc3035]
7. Gou CY, Ha MW, Li H. Notch1 expression and its significance in human gastric Ccancer. Zhongguo Yike Daxue Xuebao 2010; 39: 356-358
8. Huang PX, Wang JS, Tao CH, Huang ZG, Liu ZJ. Expression of iNOS, MMP-2 and Notch1 in gastric cancer and their correlation with metastasis. Tongji Daxue Xuebao 2009; 30: 53-57
9. Kang H, An HJ, Song JY, Kim TH, Heo JH, Ahn DH, Kim G. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Histopathology 2012; 61: 576-586 [PMID: 22691042]
10. Li DW, Wu Q, Peng ZH, Yang ZR, Wang Y. Expressions and clinical significance of Notchl and NF-KB in gastric cancer. Tumor 2007; 27: 458-461
11. Liu B, Sun LB, Chen WQ, Zhou JD, Wu JC. Expression and clinical significance of Notch1 and HER2 in gastric carcinoma. Najing Yike Daxue Xuebao 2012; 32: 236-240
12. Piazzi G, Fini L, Selgrad M, Garcia M, Daoud Y, Wex T, Malfertheiner P, Gasbarrini A, Romano M, Meyer RL, Genta RM, Fox JG, Boland CR, Bazzoli F, Ricciardiello L. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget 2011; 2: 1291-1301 [PMID: 22249198]
13. Sun Y, Gao X, Liu J, Kong QY, Wang XW, Chen XY, Wang Q, Cheng YF, Qu XX, Li H. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers. Arch Pathol Lab Med 2011; 135: 451-458 [PMID: 21466361]
14. Wang YM, Yang JJ, Quan MM, Zhang HY, Wang GX, Liang Y. The expressions and significance of HES1, ICN1 and Notch1 in gastric cancer. Zhongguo Weisheng Jianyan Zazhi 2012; 22: 87-89
15. Yang ZM, Wu Q, Li DW, Chen JW. Expression and clinical significance of Notchl and HIF-1α proteins in human gastric carcinoma. Shanxi Yike Daxue Xuebao 2007; 38: 498-502
16. Yang XD, Zhang H, Bai ZG, Jiang KW, Ye YJ, Wang S. Notch signaling pathway and clinicopathology in human gastric cancer. Zhonghua Putong Waike Zazhi 2009; 24: 146-148
17. Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC, Li AF, Wang AM, Kuo ML, Chi CW. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclo-oxygenase-2. Cancer Res 2009; 69: 5039-5048 [PMID: 19491270 DOI: 10.1158/0008-5472.CAN-08-4021]
18. Zhang AH, Sun HW, Su JS, Cui ZH. The expression of Notchl and DLL4 in gastric carcinoma and its clinical significance. Linchuang Waike Zazhi 2010; 18: 257-259
19. Zhang SF, Wang YL. Expression of Notch1 in gastric carcinoma tissues. Xinxiang Yixueyuan Zazhi 2012; 29: 754-756
20. Zhou MK, Zhao N, Ye YW, Chen ZF, Li Q, Zhou YN. Expression and relationship of Notch1, Jagged1 and COX-2 in gastric cancer. Zhongguo Zhongliu Linchuang Zazhi 2012; 39: 1082-1086
21. Ishigami S, Arigami T, Uenosono Y, Okumura H, Kurahara H, Uchikado Y, Setoyama T, Kita Y, Kijima Y, Nishizono Y, Nakajo A, Owaki T, Ueno S, Natsugoe S. Clinical implications of DLL4 expression in gastric cancer. J Exp Clin Cancer Res 2013; 32: 46 [PMID: 23898884 DOI: 10.1186/1756-9966-32-46]
22. Dotto GP. Notch tumor suppressor function. Oncogene 2008; 27: 5115-5123 [PMID: 18758480 DOI: 10.1038/onc.2008.225]
23. South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol 2012; 23: 458-464 [PMID: 22309843 DOI: 10.1016/j.semcdb.2012.01.017]
24. Chu D, Zhang Z, Zhou Y, Wang W, Li Y, Zhang H, Dong G, Zhao Q, Ji G. Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer. Ann Oncol 2011; 22: 2440-2447 [PMID: 21378202 DOI: 10.1093/annonc/mdq776]
25. Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G, Egan SE. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005; 65: 8530-8537 [PMID: 16166334 DOI: 10.1158/0008-5472.CAN-05-1069]
26. Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer 2010; 116: 5676-5685 [PMID: 20737536 DOI: 10.1002/cncr.25551]
27. Chang HH, Lee H, Hu MK, Tsao PN, Juan HF, Huang MC, Shih YY, Wang BJ, Jeng YM, Chang CL, Huang SF, Tsay YG, Hsieh FJ, Lin KH, Hsu WM, Liao YF. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res 2010; 16: 4411-4420 [PMID: 20736329 DOI: 10.1158/1078-0432.CCR-09-3360]
28. Thélu J, Rossio P, Favier B. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol 2002; 2: 7 [PMID: 11978185 DOI: 10.1186/1471-5945-2-7]
29. Proweller A, Tu L, Lepore JJ, Cheng L, Lu MM, Seykora J, Millar SE, Pear WS, Parmacek MS. Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 2006; 66: 7438-7444 [PMID: 16885339 DOI: 10.1158/0008-5472.CAN-06-0793]
30. Panelos J, Batistatou A, Paglierani M, Zioga A, Maio V, Santi R, Pimpinelli N, De Giorgi V, Santucci M, Massi D. Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Mod Pathol 2009; 22: 959-968 [PMID: 19396152 DOI: 10.1038/modpathol.2009.55]
31. Sekine A, Akiyama Y, Yanagihara K, Yuasa Y. Hath1 up-regulates gastric mucin gene expression in gastric cells. Biochem Biophys Res Commun 2006; 344: 1166-1171 [PMID: 16647036 DOI: 10.1016/j.bbrc.2006.03.238]
32. Lee SH, Jeong EG, Yoo NJ, Lee SH. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. APMIS 2007; 115: 1357-1363 [PMID: 18184405 DOI: 10.1111/j.1600-0463.2007.00751.x]
33. Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang MC, Huang KH, Li AF, Chi CW, Hsieh RH, Ku HH, Yeh TS. Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog 2012; 51: 939-951 [PMID: 21976141 DOI: 10.1002/mc.20865]
34. Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J, Sung JJ. Dysregulation of cellular signaling in gastric cancer. Cancer Lett 2010; 295: 144-153 [PMID: 20488613 DOI: 10.1016/j.canlet.2010.04.025]
35. Piazzi G, Bazzoli F, Ricciardiello L. Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle 2012; 11: 4323-4327 [PMID: 23085543 DOI: 10.4161/cc.22388]
36. Katoh M, Katoh M. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer. Int J Oncol 2007; 31: 461-466 [PMID: 17611704]
37. Katoh M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 2007; 6: 832-839 [PMID: 17568183 DOI: 10.4161/cbt.6.6.4196]